stale bull

I am now a stale bull.

RP, flog this dog to DS for $250M

Benefits to DS:

1. $70M cash
2. $28M Inavir revenue (present value of paying Bota $5M p.a. for next 10 yrs)
3. $160M BARDA tied cash grant, with potential for more BARDA funding
4. Vapendavir (zero outlay for $30M sunk cost)
5. 100% LANI revenue for 10+ years

For that purchase, DS doesn't have to outlay much in the way of costs, except Ph 3 Vap and sales for LANI and Vap.